Product, Process and Packaging Optimization for Development of Stable Oral Capsule Formulation of Second-line Anti- Tubercular drug
Main Authors: | Amit Mukharya, Shivang Chaudhary, Nitin Laddha, Arun Kumar Misra |
---|---|
Format: | Article |
Language: | English |
Published: |
Archives of Global Professionals
2011-01-01
|
Series: | Archives of Pharmacy Practice |
Online Access: | http://www.archivepp.com/article.asp?issn=2045-080X;year=2011;volume=2;issue=4;spage=143;epage=150;aulast=Mukharya;type=0 |
Similar Items
-
Splenic Tubercular Abscess in an Immunocompromised Patient–Rapid Diagnosis by Line Probe Assay
by: Savita V. Jadhav, et al.
Published: (2013-09-01) -
Tubercular arthritis of knee: Navigating the diagnostic dilemma
by: Nitin P Ghonge, et al.
Published: (2020-01-01) -
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
by: Stephen Patterson, et al.
Published: (2016-05-01) -
Multifocal Tubercular Dactilytis of Feet with Tubercular Ulcers
by: Aditi Jha, et al.
Published: (2016-06-01) -
Extraction, quantification, formulation and evaluation of oral capsules from burdock fruits
by: F. Arab, et al.
Published: (2017-11-01)